BioBlast Pharma (ORPN) Reports Q3 Loss of $0.28/Share

November 29, 2016 8:03 AM EST
Get Alerts ORPN Hot Sheet
Trade ORPN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

BioBlast Pharma (NASDAQ: ORPN) reported Q3 EPS of ($0.28), versus ($0.25) reported last year.

Cash, cash equivalents and short-term bank deposits as of September 30, 2016, were $12.9 million, compared to $15.7 million as of June 30, 2016, primarily reflecting the Company’s third quarter operating expenditures. The Company expects to have at the end of 2016 between $8 to $9 million in cash, cash equivalents and short-term bank deposits.

For earnings history and earnings-related data on BioBlast Pharma (ORPN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment